Vaccinia virus armed with IL-21 can cure murine colorectal cancer liver metastases via intravenous administration

Read full text Summarise with VIRAT
Authors: Na Wang, Yijia He, Junzhi Yu, Yimeng Xia, Yangyang Jia, Ruixian Liu, Yanru Zhang, Yan Liu, Shiyang Ning, Louisa Chard Dunmall, Zhe Zhang, Yaohe Wang
Cited by: 0
References: 33

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background Liver metastases of colorectal cancer are one of the leading causes of mortality in patients with colorectal cancer. Oncolytic virus immunotherapy has demonstrated significant potential in tumor treatment; however, most oncolytic viruses are currently administered via intratumoral injection, limiting their broader clinical application. Methods In this study, we used an oncolytic vaccinia virus VVLΔTK-STCΔN1L-mIL21 expressing interleukin-21 to treat a male BALB/c murine model of colorectal cancer liver metastases (CRLM) via intravenous administration. This approach aimed to explore the feasibility of oncolytic viruses reaching distant tumors through systemic delivery and exerting therapeutic effects, thereby broadening the application scope of oncolytic viruses. We examined the effects of intravenous vaccinia virus treatment on the survival of mice with colorectal cancer liver metastases. Furthermore, we performed comprehensive analyses of the impacts of vaccinia virus therapy on T lymphocytes in these mice using flow cytometry, in vitro interferon (IFN)-γ release assays, and RNA sequencing. Results Our findings revealed that VVLΔTK-STCΔN1L-mIL21, when administered intravenously, successfully reached liver tumor foci and persisted for an extended period, significantly prolonging the survival of mice with CRLM. Further analysis showed that VVLΔTK-STCΔN1L-mIL21 treatment promoted the expansion of CD8 + T cells and effector memory T cells (CD8 + CD44 hi CD62L lo T EM ) while reducing regulatory T cells. It also enhanced the secretion of IFN-γ by splenic CD45 + lymphocytes in vitro, inhibited the expression of immune checkpoint molecules and effector molecules on CD8 + T cells, and promoted the generation of T follicular helper cells. Conclusions VVLΔTK-STCΔN1L-mIL21 can effectively reach liver metastases via tail vein injection and exert potent antitumor effects, significantly extending the survival of mice.

Fields of Study & Subjects

Virus-based gene therapy research Immunotherapy and Immune Responses Bacterial Cancer Therapy

Publication details

Journal / source
Journal for ImmunoTherapy of Cancer
Volume
14
Issue
3
Pages
e012479–e012479
Publication date
1 March 2026
Language
EN